This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) creates new possibilities via medicine to cure diseases and improve people’s lives, and over the past year, marked gains in investors’ portfolios.

Since July 2021, Vertex Pharmaceuticals stock’s one-year return has outperformed several of the world’s most popular tech and consumer discretionary stocks: Tesla Inc. (NASDAQ:TSLAApple Inc (NASDAQ:AAPL), Starbucks Corporation (NASDAQ:SBUX), NVIDIA Corporation (NASDAQ:NVDA) and Microsoft Corporation (NASDAQ:MSFT).

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko and Trikafta/Kaftrio.

Vertex was founded in 1989 and is headquartered in Boston, Massachusetts.

Here’s how the returns break down from July 2021 to the present: 

  • Tesla is down from $677.92 to $669.11 for a return of -1.30%
  • Starbucks is down from $113.41 to $77.87 for a return of -31.34%
  • Microsoft is down from $271.60 to $255.52 for a return of -5.92%
  • Nvidia is down from $202.12 to $145.74 for a return of -27.89%
  • Apple is down from $137.27 to $135.94 for a return of -0.97%
  • And finally, Vertex is up from $202.21 to $282.35 for a return of 39.63%

 

Total
0
Shares
Related Posts
Read More

Apple, Microsoft, Disney And American Express Continue To Plummet: Dow Jones Index Has Worst First Half In Decades

The U.S. Stock Market has had a rough 2022 so far and the SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA: DIA) has been no exception to that. Since the start of the calendar year, the index has lost close to 6,000 points as inflation continues to rise and consumer spending falls.

APPL